Mobilized CD34-selected Peripheral Blood Stem Cell graft for anemia, refractory, with excess of blasts

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Jan 2015: Trial registered, NCT02345850
  2. 5 Oct 2020: Trial completed, NCT02345850

The trials

NCT02345850: Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

State
Completed
Phase
Phase 3
People
346 taking part
Started
Aug 2015
Primary completion
5 Oct 2020
Arms
CD34 Selection Arm
Results
Posted on the registry
  1. 26 Jan 2015: Trial registered
  2. 5 Oct 2020: Trial completed
  3. 21 Dec 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Surgery or procedure.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.